Back to jobs

Vice President, Clinical Development, Danicamtiv (DANI)

Princeton, New Jersey, United States, South San Francisco, California, United States

About Us 

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.
 
Led by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
 
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
 
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.
 
These values are the foundation of our work, empowering us to make a real difference, every day.
 
 

The VP, Clinical Development will have direct responsibility as Clinical Lead accountable for clinical development strategy and execution across one or more programs. 

The successful candidate will be a highly credible physician leader, a strong people manager, and a trusted thought partner to the program GPH, other VP-CDLs, the CMO, the CEO, and Executive Committee members.

Key Responsibilities 

Danicamtiv Program – Clinical Lead 

  • Serve as the Clinical Lead for the Danicamtiv program, with end-to-end accountability for clinical strategy and execution, including protocol development and approval and regulatory interactions.
  • Lead the Danicamtiv Clinical Strategy Team (CST) with cross-functional leadership in development and execution of the Danicamtiv clinical development plan.
  • Own clinical development plans, and protocol design, with critical input for indication selection and target product profile (TPP) development for Danicamtiv.
  • Lead clinical decision-making based on emerging data, benefit–risk assessments and evolving regulatory interactions and expectations.
  • Act as the primary clinical development point of contact for regulatory interactions, investigators, and key opinion leaders related to the Danicamtiv program.
  • Partner closely with colleagues from Clinical Operations, Biometrics, Regulatory, and Medical Affairs to ensure seamless oversight and execution of clinical trials across the Danicamtiv program. 

Executive & External Engagement 

  • Act as a senior clinical representative for discussions with the Kardigan Executive Committee, as needed. 
  • Present clinical strategy, study progress, and risks to internal leadership and, when needed, to the Kardigan Executive Committee and Board of Directors. 
  • Represent the Kardigan clinical development function externally at scientific meetings, advisory boards, and interactions with Key Opinion Leaders, related to the  Danicamtiv programs and potentially for other drug programs, as well. 

Qualifications 

  • MD (or equivalent medical degree); board certification and clinical practice experience in cardiology strongly preferred. 
  • 15+ years of experience in clinical development within biotechnology and/or pharmaceutical companies– experience in cardiomyopathy and/or heart failure drug development and deep knowledge of cardiomyopathy and heart failure clinical care delivery, clinical research landscape, scientific literature, competitive drug development environment, and regulatory pathways strongly preferred.
  • Demonstrated experience serving as clinical lead for a major drug program or asset, ideally through key late-stage development milestones. 
  • Strong understanding of cardiovascular clinical trial designs, endpoints in cardiovascular trials, and regulatory strategies for cardiovascular drug development.
  • Well-developed relationships with key external experts in the cardiomyopathy/heart failure field and demonstrated track record of overseeing external research collaborations for cardiomyopathy/heart failure topics.  
  • Experience with genetic screening initiatives for clinical research and clinical care delivery purposes desired.
  • Proven ability to influence and lead cross-functional teams.
  • Experience in late-stage development and/or regulatory submissions.
  • Prior experience managing or mentoring other MDs.
  • Experience in a high-growth or emerging biotech environment.
  • Track record of effective partnership with a CMO or senior medical leadership.

 Leadership Characteristics 

  • Highly credible clinical development leader with strong clinical judgment.
  • Strategic thinker who balances rigor with speed and pragmatism.
  • Strong collaborator and people leader with extensive experience leading and building teams.
  • Comfortable operating in ambiguity and helping design future-state organizations.

Exact Compensation may vary based on skills, experience and location.

Pay range

$340,000 - $416,000 USD

Create a Job Alert

Interested in building your career at Kardigan? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf

Education

Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Kardigan’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.